Please ensure Javascript is enabled for purposes of website accessibility

Athenahealth, Inc. First-Quarter Earnings Soar As Cost-Cutting Pays Off

By Keith Speights – Apr 27, 2018 at 8:16AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The cloud-based healthcare technology company's revamping of its sales organization boosts the bottom line significantly.

Investors had one primary question for athenahealth, Inc. (ATHN) prior to the company's first-quarter earnings report: Can the momentum continue? Athenahealth ended 2017 on a positive note, returning to solid growth in the fourth quarter.

The cloud-based healthcare applications provider answered that question after the market closed on Thursday. Here are the highlights from Athenahealth's quarterly update. 

Physician holding tablet

Image source: Getty Images.

Athenahealth results: The raw numbers


Q1 2018 

Q1 2017 

Year-Over-Year Change


$320.3 million (old revenue recognition)

$329.4 million (new revenue recognition)

$285.4 million


Net income from continuing operations

$31.1 million (old revenue recognition)

$19.1 million (new revenue recognition)

($1.4 million)


Adjusted earnings per share (EPS)

$0.96 (old revenue recognition)

$1.25 (new revenue recognition)



Data source: Athenahealth. 

What happened with Athenahealth this quarter?

What's up with two different sets of numbers in the first quarter? Athenahealth implemented a new revenue recognition standard effective Jan. 1, 2018. Because of this new standard, it's like comparing apples to oranges using the 2018 first-quarter results under the new revenue recognition approach and the results from the prior-year period. The good news, though, is that Athenahealth provided information on what the recent first-quarter results would have been if the old revenue recognition model had been used.

Many companies would be happy campers with the year-over-year sales growth of over 12% reported by Athenahealth. This performance exceeded what some observers expected. However, it's significantly lower than what the company has been accustomed to in the past and reflected a decline from revenue recorded in the fourth quarter of 2017. 

The great news for Athenahealth was its tremendous improvement on the bottom line. This improvement is a direct result of the company's cost-cutting initiative announced in October 2017. Athenahealth's selling and marketing expense decreased 24% compared to the prior-year period, savings that rolled down to its net income.

There was also good news with the company's network growth metrics. The number of providers on athenaOne Collector increased 15% year over year, while the number of providers on both athenaOne Communicator and Clinicals applications jumped 20% higher than the prior-year period. Covered lives on Athenahealth's population management platform increased by 21% year over year. The biggest improvement came from the athenaOne hospital product, with discharge bed days soaring 194% from the first quarter of 2017.

Aside from the financial and network growth results, the biggest news for Athenahealth in the first quarter was that the company's board of directors appointed a new chairman -- former GE chairman and CEO Jeffrey Immelt. Jonathan Bush had been chairman of the board since the company's founding.   

What management had to say

Athenahealth CEO Jonathan Bush stated, "We had a good start to the year. We continued to build on our position as the most connected network in healthcare with strong growth in the number of providers on our network during the first quarter." Bush added:

We remain focused on transitioning to a platform company that aims to unleash our collective potential to transform healthcare. Throughout 2018, we're committed to taking more work off of clients' plates and delivering additional capabilities that deepen our services, lower costs, and enable a better experience for patients and providers.

Looking forward

Athenahealth reaffirmed the full-year 2018 guidance provided at its investor summit held on Feb. 15, 2018. The company continues to expect revenue between $1.31 billion and $1.38 billion in 2018. GAAP operating income is projected to be in the range of $108 million to $152 million. Athenahealth projects that non-GAAP operating income will be between $210 million and $235 million. 

One thing for investors to watch closely in the coming months is how much new business Athenahealth picks up. The company cut back significantly in the sales and marketing area. Such cuts can sometimes help reduce costs but ultimately result in lower sales. However, Athenahealth's outlook calls for continued sales growth, so the company could be able to be more productive even with fewer staff.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Athenahealth. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

athenahealth, Inc. Stock Quote
athenahealth, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.